By name: "KSB-D10-K0031" description: "Pharmacokinetic-Pharmacodynamic Modeling: Population PK/PD analysis, exposure-response relationships, drug interaction modeling, special popul..." version: "1.0.0" domain: "D10" domain_name: "Benefit-Risk Assessment" type: "Knowledge" proficiency_level: "L1" bloom_level: "understand" triggers: - "explain pharmacokinetic-pharmacodynamic modeling" - "what is pharmacokinetic-pharmacodynamic modeling" - "explain pharmacokinetic-pharmacodynamic modeling" epa_mapping: "EPA-03, EPA-05, EPA-08" cpa_mapping: "CPA-02, CPA-03" regulatory_refs: "CIOMS-X, ICH-E2E"
KSB-D10-K0031: Pharmacokinetic-Pharmacodynamic Modeling
Overview
Domain: D10 - Benefit-Risk Assessment Type: Knowledge Proficiency Level: L1 (Novice - Direct supervision required) Bloom Level: Understand
Description
Population PK/PD analysis, exposure-response relationships, drug interaction modeling, special population considerations
Context
- Major Section: Benefit-Risk Assessment Theoretical Foundation and Decision Science
- Section: Mathematical Modeling and Simulation Frameworks
EPA Mapping
- EPA-03:3006-3008
- EPA-05:3011-3012
- EPA-08:3018-3019
CPA Pathway
- CPA-02, CPA-03
Regulatory References
- CIOMS-X
- ICH-E2E
Instructions
When this skill is activated, Claude should:
- Demonstrate L1 proficiency in pharmacokinetic-pharmacodynamic modeling
- Apply understand level cognitive skills to explain the topic
- Reference relevant regulatory guidance (CIOMS-X, ICH-E2E)
- Connect to related EPAs: EPA-03, EPA-05, EPA-08
Key Competencies
- Population PK/PD analysis, exposure-response relationships, drug interaction modeling, special population considerations
Assessment Criteria
- Can explain core concepts independently
- Demonstrates understanding of regulatory context
- Applies knowledge appropriately to PV scenarios
Related Skills
- Other D10 skills in Mathematical Modeling and Simulation Frameworks
- Cross-domain integrations per DAG architecture
Generated from PV KSB Framework v1.0 | 2025-12-31